Efficiency under quantile regression: What is the relationship with risk in the EU banking industry?
Review of Financial Economics · 2011-05 · 20 (2) · 84-95
DOI: 10.1016/j.rfe.2011.04.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Review of Financial Economics, online erschienen am 08.04.2011. Verfasst von Anastasia I. Koutsomanoli‐Filippaki und 1 weiteren Autor:innen. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
This study estimates cost efficiency under a quantile regression framework. Our purpose is to investigate whether cost efficiency differs across quantiles of the conditional distribution. Efficiency scores are derived using the distribution‐free approach. Results show that for higher conditional distributions, efficiency scores are lower. In a second stage analysis, we examine the relationship between efficiency and risk, measured as distance to default. Cross section regressions show that the higher the risk, the lower the level of efficiency. The magnitude and the significance of the coefficient of the distance to default increases for conditional distributions associated with lower levels of efficiency.
Zitieren
APA
Koutsomanoli‐Filippaki, A. I., & Mamatzakis, E. C. (2011). Efficiency under quantile regression: What is the relationship with risk in the EU banking industry?. Review of Financial Economics, 20(2), 84-95. https://doi.org/10.1016/j.rfe.2011.04.001
Vancouver
Koutsomanoli‐Filippaki AI, Mamatzakis EC. Efficiency under quantile regression: What is the relationship with risk in the EU banking industry?. Review of Financial Economics. 2011;20(2):84-95. doi:10.1016/j.rfe.2011.04.001
BibTeX
@article{KoutsomanoliFilippaki2011,
author = {Koutsomanoli‐Filippaki, Anastasia I. and Mamatzakis, Emmanuel C.},
title = {Efficiency under quantile regression: What is the relationship with risk in the EU banking industry?},
journal = {Review of Financial Economics},
year = {2011},
volume = {20},
number = {2},
pages = {84--95},
doi = {10.1016/j.rfe.2011.04.001}
}
EUVIMED